The Series B funding was led by Cathay Innovation and Zebox Ventures (CMA CGM incubator) in early January.
It follows the trend of French AI startups raising substantial funds, with Nabla being one of the latest after MistralAI at the end of the previous year.
A Copilot for Doctors
Nabla aims to create an assistant capable of generating doctors’ clinical notes through AI, aiming to save valuable time for healthcare personnel involved in transcription.
Launched in March, Nabla Copilot uses natural language processing to produce instant medical reports, including medical coding.
According to the company, clinicians save 2 hours per day on clinical documentation with the Copilot. 90% of them have reported a significant reduction in fatigue.
Currently, Nabla reports that 20,000 providers are using the assistant.
Conquering the US
The company plans to leverage these new investments to expand its presence in both the French and American healthcare markets.
They already have an office in Boston.
The Free plan, available at $0/month, offers up to 30 consultations monthly, EHR integration, and unlimited access for interns and residents. This plan allows users to explore Copilot’s capabilities without any financial commitment.
For individual clinicians and small practices, the Pro plan, priced at $119/month, provides unlimited consultations, seamless EHR integration, and a trial period for users to experience the full benefits of Copilot.
Enterprises, including hospitals and telehealth companies, can explore Copilot Enterprise. This fully customizable solution includes unlimited consultations, EHR integration, custom integrations, automation, tailored machine learning models, and SAML SSO. Interested parties can contact Copilot for personalized plans based on their specific needs.